Reduced left ventricular ejection fraction and sudden cardiac death in patients undergoing revascularization: time to remember the other players of the game.
We strongly believe that relying solely upon ameliorating myocardial ischemia by coronary revascularization may be an inadequate clinical strategy for the prevention of sudden cardiac death (SCD) in dialysis and chronic obstructive pulmonary disease (COPD) patients. More importantly when predicting SCD risk in patients with coronary artery disease one should assess not only left ventricular ejection fraction but also the other clinical parameters such as renal replacement therapy and COPD.